• Metadoro
  • Prodotti
  • Notizie e analisi

Notizie e analisi

Leggi le notizie dai mercati a cura dei membri della nostra community
09.01.2025
VeChain Is Suffering on Rising Borrowing Costs

VeChain (VET) has fallen 12.7% this week, trading at $0.0445, underperforming the broader cryptocurrency market. Bitcoin (BTC), the leading cryptocurrency, has declined by 5.6% to $93,220, with bearish momentum building as it approaches key support at $89,000-$91,000. This decline is largely attributed to tightening monetary conditions in the United States, which continue to weigh on risk assets. Investor confidence is further shaken by significant net outflows from spot BTC-ETFs, which lost $583 million on Wednesday, marking the second-largest single-day outflow on record.

If BTC falls below the critical support level of $89,000-$91,000, VeChain is likely to extend its losses, with prices potentially declining another 10% to $0.0400. A sustained drop in BTC could push VET even lower, towards $0.0300. Conversely, a strong rebound in BTC prices to the $100,000 level could drive VET back up to $0.0500, representing a recovery of approximately 12% from current levels.

16.01.2025
Delta Is Taking Off To Update Its Highs

Delta Air Lines stock rose markedly by low double digits in the first ten days of the new year. The U.S. carrier has served more than 200 million customers in 2024, when it was also recognized by J.D. Power, a leading American data analytics and consumer intelligence company, for being No. 1 in First/Business and Premium Economy Passenger Satisfaction. Travelers became more willing to spend extra money for swanky seats when meeting a high level of service. Delta is just positioning itself as the nation's premium airline. And what's more important, its Christmas quarter's earnings reportedly surpassed average analyst pool projections. Driven by stronger travel demand, smart financial management and capacity discipline, Delta business provided last three-months' profit of $1.85 per share vs $1.28 at the same period one year ago, compared to $1.75 in consensus estimates. On January 10, the airline industry leader put its future profit levels within a range between $0.70 and $1 per share in the current quarter through the end of March, while analyst expectations were focused on $0.77 cents, according to data compiled by LSEG. The starting months of each year always perform worse. It is clear that all carriers made losses in the Covid years of 2020-2022, but Delta profits only recovered into a range from $0.25 to $0.45 in the first quarter of 2023 and 2024, respectively, but Q1 profit numbers varied from $0.75 to $0.96 even in the three blessed years before the pandemic. Delta added that it is forecasting annual earnings in excess of $7.35 a share, which would be the highest in its 100-year history, based on its planned revenue growth of 7% to 9% in the March quarter from a year ago. The announcement could be compared to an adjusted profit of $6.16 a share in 2024. The company happily breaks through ticket prices' rising effects, almost undisturbed by a reduction in airline seats in the domestic market, which was peculiar for most carriers. Thus, new expectations created a fertile ground for setting new price records, even though price movements on Delta charts look most convincing among its other American rivals.

By the way, Citigroup analysts freshly updated their outlook on Delta Air Lines shares to raise their price target to $80 from the previous $77, vs the actual range around $65 per share where the stock just came after a reasonable market correction from last week's and all-time highs. Citigroup said it has included factors like higher revenue per available seat mile, projections of slightly lower fuel prices, increased taxation, a minor rise in share count, and the incorporation of fourth-quarter 2024 results into their financial model, which has projected Delta's profit at $7.49 per share in 2024 and $8.72 in 2025. Delta shares are Buy-rated at Citi, and we agree with their positive estimates in general, while keeping in mind even better price goals somewhere between $82.5 and $85.

14.01.2025
Tezos Is Seen Hodling above $1.200

Tezos (XTZ) has declined slightly by 0.2% this week, trading at $1.249, following Bitcoin’s (BTC) drop to $89,158, which triggered widespread altcoin sell-offs due to concerns of a potential further decline in BTC to $80,000. However, Bitcoin managed to hold above the critical support level at $89,000-$91,000, offering some relief to the broader crypto market.

Speculation about a shift in U.S. trade policy has provided additional support to crypto assets. Reports suggest the new U.S. administration may pursue a gradual increase in tariffs rather than an abrupt hike, which could help alleviate inflationary pressures and lead to a less aggressive monetary stance from the Federal Reserve.

This development is a positive signal for the cryptocurrency market and may help Tezos maintain its position above the key support level of $1.200.

23.01.2025
Ontology Is Sliding Towards $0.2000

Ontology (ONT) is down 2.3% this week, trading at $0.2176, in line with the broader crypto market where Bitcoin (BTC) has declined 2.0% to $101,632. While the new U.S. administration has made some strides toward fairer crypto regulation, Donald Trump has remained silent on the highly anticipated issue of adding Bitcoin to U.S. federal reserves.

Market speculation is rampant, with figures like BlackRock CEO Larry Fink suggesting Bitcoin could surge to $700,000 per coin if sovereign wealth funds begin accumulating. Other forecasts predict Bitcoin reaching $250,000 by year-end. While such projections could foster optimism, the lack of decisive action or announcements regarding U.S. crypto reserves is weighing heavily on the market.

For Ontology, the situation remains bearish. Having breached the critical support at $0.2500 last week, the token is now approaching the $0.2000 level. A failure to provide clear evidence or statements about U.S. federal crypto reserve plans could see ONT fall even further, breaching the $0.2000 mark and deepening its losses.

14.01.2025
Merck Becomes Interesting to Be Added to a Portfolio

Merck & Co (MRK) stocks have shown signs of becoming a compelling buy opportunity. Over the past six months, the stock has been in a downtrend, declining 29.8% to $94.50 per share. However, since mid-November, MRK has demonstrated a reversal of momentum, rebounding by 10.0% to reach $104.87 on December 5. Following a brief pullback and consolidation period, the stock has retested the downtrend resistance and appears poised to continue its upward trajectory.

With prices currently positioned to target $110.00, this represents a potential 9-10% upside from the present levels. Setting a stop-loss at $93.50 aligns with a prudent risk management strategy, providing protection against further downside while allowing for upside potential. The recent consolidation phase further supports the case for a breakout, making this an attractive moment to consider initiating or adding to a position in MRK.

Legitimate Cannabis is in Demand Again: Tilray

Tilray is another cannabis producer from Canada. Its stocks surged amid expectations of marijuana legalisation in the United States, but are now trading far below their peaks of $67 in 2021. The current price at $3 per share, is somewhat attractive as long-term investments.

The majority of TLRY revenues do not come from marijuana sales although the company does control 8.3% of the cannabis market in Canada. Tilray receives 34% of its revenues from cannabis sales. It is the only cannabis producer in Canada that has positive adjusted EBITDA, and sustainable financials overall. The company has cash and cash equivalents of $433.5 million with a debt of $593 million.

Tilray has large greenhouses in Canada and can easily boost production of cannabis if it becomes legal for the whole territory of the United States. The company has invested $165.7 million into its U.S. company MedMen that conducts operations in many American states.

2843
Legitimate Cannabis is in Demand Again: Canopy Growth

Canopy Growth stocks were the most popular before marijuana became legal in Canada. However, after weak financial results performed for a long period of time, CGC prices returned to where they were at the end of 2018. The company’s latest earning report for Q3 2022 provided mixed impressions as revenues were down by 10% year-on-year to $117.9 million, while gross margin was up to 10% from -52%. Cash and cash equivalents were down by 42% year-on-year to $1.1 billion. The amount of cash decreased dramatically as the company is heavily investing in its business in the United States, where it has greater potential than Canada. The company’s management sees this expansion as once in a lifetime opportunity and is willing to bet everything on the U.S. in its effort to consolidate its operations. CGS is trying to get control of its existing businesses in the U.S. where it already has a share of the market: Jetty Extracts (vaping), Wana Brands (a maker of marijuana-infused edibles) and Acreage (a multi-state operator).

Biosteel sport beverages, that are distributed via Walmart and delivered sales up by 299% year-on-year during the reporting quarter, is the only profitable segment for CGS. This is not the best result for a company that specialises in recreational cannabis production. Investors seem to appreciate management’s efforts to risk everything for expansion in the U.S., but the future of the company is entirely dependent on this venture.

3070
Low Risk Purchases in the Bearish Market: Salesforce

Salesforce is a leader of the CRM systems segment. Its stocks are trading at 47% off their peaks. The company continues to post strong business growth despite being in the market for a long time. It has strong financials and abilities to reward its investors. The last quarter revenue reported by Salesforce rose by 14% year-on-year to $7.8 billion, while its operational margin grew by 290 basis points to 22.7%. This is quite impressive as the company suffered because the strong Dollar undermined its revenues outside the U.S. The company’s management has also approved a buy-back program for $1.7 billion.

Management estimates the company will increase its operational margin to 25% in the next couple of years and boost its revenues to $31 billion during this fiscal year, or by 17%. Salesforce announced the cut of 10% of its staff in order to increase profitability. This is quite a common strategy in the tech sector to keep business expansion going.

The company is also active in the M&A market. The last of its acquisitions is the Slack platform that has posted revenues up by 46% during the reporting quarter. Thus, investors may have a wide variety of outstanding products as they buy CRM stocks.

2199
Low Risk Purchases in the Bearish Market: Visa

Visa stocks are trading at 10% of their peak values, which is an excellent result in the falling market compared to many other prominent shares. The company has very strong financials as number of financial transactions processed by the company continue to increase rapidly despite strong pandemic growth, which has now come to a standstill. Lockdowns promoted online payments and customers got used to this kind of transactions. Visa revenues rose by 19% year-on-year during Q3 2022. The company has bought back its shares for $11.6 billion and paid $3.2 billion during the last twelve months.

Moreover, Visa is benefiting from the reopening of the travel industry and the recovering sector. The number of international transfers increased by 36% year-on-year. The company estimates that overseas travel to Asia have recovered only by 70% by this time. So, China’s reopening may boost its revenues further up.

2620
294

Unisciti alla nostra community

Condividi le tue osservazioni professionali e amatoriali, scambia esperienze, anticipa gli sviluppi

Categoria
Tutti
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Strumenti
Autore
Tutti
Metadoro
Collaboratori